Dr. Ngozi Anachebe, associate dean for admissions and student affairs at Morehouse School of Medicine, join us to discuss problems—and opportunities the pandemic has presented for the incoming class of 2022.
Read MoreA conversation with Dr. Diane George, CMO of Henry Ford Medical Group Primary Care, about her health system’s innovative approach to telehealth during the pandemic.
Read MoreDiscussion with AMA’s Chief Health and Science Officer, Dr. Mira Irons, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering travel news post-Memorial Day weekend, as well as recent CDC announcements pertaining to mask guidance for summer camp and investigating «breakthrough infections.»
Read MoreA look at how Ochsner Health was able to free up ICU beds by implementing a remote monitoring program to treat COVID-19 patients.
Read MoreA discussion with Dr. Tom Frieden, former director of the CDC and president and CEO of Resolve to Save Lives in New York, about his work to address vaccine hesitancy, including the role of politics and finding messaging that resonates.
Read MoreA discussion with Dr. Megan Ranney, a practicing emergency physician, researcher and national advocate for innovative approaches to public health about gun violence and how physicians can play a role in a preventing it.
Read MoreDr. Sandra Fryhofer, the AMA liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), discusses the committee’s recommendation to lift the pause on the Johnson & Johnson vaccine and what physicians need to know to help address patients’ concerns.
Read MoreA discussion about the benefits and challenges of vaccine credentials and the ethical considerations that need to be addressed in the months ahead.
Read MoreA discussion about how to combat anti-Asian racism both during the pandemic and beyond and physicians’ important role in that effort.
Read MoreFriend of the show, Dr. Sandra Fryhofer—the AMA liaison to the CDC’s Advisory Committee on Immunization Practices and the AMA’s representative on the COVID-19 vaccine work group—joins us for a quick and comprehensive look at the emerging details regarding the J&J/Janssen COVID-19 vaccine.
Read More